Rate My Professor Alicia Jenkins

Her research focuses on clinical management of type 1 diabetes, predicting and preventing diabetes complications, leveraging technologies like insulin pumps, continuous glucose monitoring, and telemedicine, alongside global health initiatives for equitable diabetes care. Her team undertakes observational studies—including those with Indigenous Australians—clinical trials, biomarker analyses, technology assessments, and investigations into researcher well-being. With more than 400 publications garnering over 19,000 citations and a Scopus h-index of 53, notable works include the textbook Lipoproteins in Diabetes Mellitus (2nd ed., Humana Press, 2023), “Long-term glycaemic variability and vascular complications in type 2 diabetes” (J Clin Endocrinol Metab, 2020), “Estimated insulin sensitivity in type 1 diabetes adults” (Diabetes Res Clin Pract, 2020), “An assessment of clinical continuous glucose monitoring targets” (Diabetes Technol Ther, 2023), and “Telomeres do not always shorten over time in individuals with type 1 diabetes” (Diabetes Res Clin Pract, 2022). Awards include the Australian Diabetes Society Kellion Award (2019), Royal Australasian College of Physicians International Medal (2022), NHMRC CTC Academic Excellence Award (2019), and University of Melbourne team research award (2020). She is Chief Editor of her textbook series, Co-Director of the Australian Cardiovascular Alliance Precision Medicine Flagship, International Diabetes Federation Western Pacific Chair Elect (2023–2025), and has served on the Australian Diabetes Society Council and Insulin For Life Board since 2000.